Skip to content
PICO Portalanswers from OpenAlex

Transcriptional Pathway Signatures Predict MEK Addiction and Response to Selumetinib (AZD6244)

PaperCitations, authors & open-access status

Transcriptional Pathway Signatures Predict MEK Addiction and Response to Selumetinib (AZD6244) is a paper indexed in PICO Portal from OpenAlex.

How many citations does Transcriptional Pathway Signatures Predict MEK Addiction and Response to Selumetinib (AZD6244) have?

PICO Portalcitation count

Transcriptional Pathway Signatures Predict MEK Addiction and Response to Selumetinib (AZD6244) has 266 citations in the OpenAlex counts PICO Portal stores.

When was Transcriptional Pathway Signatures Predict MEK Addiction and Response to Selumetinib (AZD6244) published?

PICO Portalyear

Transcriptional Pathway Signatures Predict MEK Addiction and Response to Selumetinib (AZD6244) has 2010 year in the PICO Portal index.

What is the open-access status of Transcriptional Pathway Signatures Predict MEK Addiction and Response to Selumetinib (AZD6244)?

PICO Portaloa status

Transcriptional Pathway Signatures Predict MEK Addiction and Response to Selumetinib (AZD6244) has bronze oa status in the PICO Portal index.

What is the DOI of Transcriptional Pathway Signatures Predict MEK Addiction and Response to Selumetinib (AZD6244)?

PICO Portaldoi

The DOI for Transcriptional Pathway Signatures Predict MEK Addiction and Response to Selumetinib (AZD6244) is on the source record.

What is the PMID of Transcriptional Pathway Signatures Predict MEK Addiction and Response to Selumetinib (AZD6244)?

PICO Portalpmid

The PMID for Transcriptional Pathway Signatures Predict MEK Addiction and Response to Selumetinib (AZD6244) is on the source record.

What is the OpenAlex record for Transcriptional Pathway Signatures Predict MEK Addiction and Response to Selumetinib (AZD6244)?

PICO Portalopenalex

The OpenAlex for Transcriptional Pathway Signatures Predict MEK Addiction and Response to Selumetinib (AZD6244) is on the source record.

Related on PICO Portal

470M+ articles · 14-day free trial